USC patient RNA-Seq data shows potential of ANGLE’s Parsortix liquid biopsy for metastatic breast cancer screening

April 21, 2016 Leave a comment 2,683 Views

ANGLE plc , the specialist medtech company, has announced that the results of the University of Southern California (USC) Norris Comprehensive Cancer Center’s ongoing work with ANGLE’s Parsortix system have demonstrated the potential for the use of Parsortix as a ...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: cancer screening

USC patient RNA-Seq data shows potential of ANGLE’s Parsortix liquid biopsy for metastatic breast cancer screening

CLEARER – a machine learning approach for predicting essential genes across eukaryotes

scRNA-Seq reveals how genetic ancestry shapes immune response to influenza virus

Single-cell RNA sequencing and bioinformatics as tools to decipher cancer heterogenicity and mechanisms of drug resistance

Microwell-seq – high-throughput screening with single-cell transcriptional profiling

Postdoc position available – computational biology: tumour heterogeneity and resistance mechanisms

CellHeap – a workflow for optimizing COVID-19 single-cell RNA-Seq data processing

Automation enables high-throughput and reproducible single-cell transcriptomics library preparation